On day 2 of the offer, Mankind Pharma has been subscribed 8% so far by 11.30 AM. The issue has been subscribed 13% on April 25, the first day of bidding. Click here to subscribe the IPO.
Check the live subscription status of Mankind Pharma IPO on day 2 of the offer at 11.30 AM
Category | No.of shares offered / reserved | No. of shares bid for | No. of times of total meant for the category |
Qualified Institutional Buyers (QIBs) | 80,11,769 | 6,25,768 | 0.08 |
Non Institutional Investors(NIIS) | 60,08,827 | 30,97,952 | 0.52 |
Retail Individual Investors (RIIs) | 1,40,20,596 | 21,46,495 | 0.15 |
Total | 2,80,41,192 | 58,70,215 | 0.21 |
(Source: BSE)
ManKind Pharma is one of the largest pharma companies of India, which focuses on the development of a diverse range of pharma products across acute and chronic therapies, along with various consumer healthcare products including marquee brands like Manforce, Prega News, Gas-O-Fast and Unwanted Kit.
Mankind Pharma IPO important details
Open date | April 21 |
Close date | April 25 |
Lot size | 13 |
IPO size (Rs crore) | Rs 4,326.36 Cr |
IPO price range (Rs) | Rs 1026-1080 per share |
Minimum investment | Rs 14,040 |
Basis of allotment date | April 28 |
Refunds date | May 2 |
Credit to demat account date | May 3 |
Listing date | May 4 |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.